Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Pediatric Genomic Medicine, |
RCV000224037 | SCV000281366 | uncertain significance | not provided | 2015-08-26 | criteria provided, single submitter | clinical testing | Converted during submission to Uncertain significance. |
Labcorp Genetics |
RCV001085633 | SCV001118161 | benign | Mucopolysaccharidosis, MPS-III-A | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001085633 | SCV002045083 | likely benign | Mucopolysaccharidosis, MPS-III-A | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001085633 | SCV001459564 | benign | Mucopolysaccharidosis, MPS-III-A | 2019-11-11 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003947736 | SCV004762759 | likely benign | SGSH-related disorder | 2019-12-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |